CareDx, Inc. · 1 day ago
Medical Director Oncologist
California
Full-time
Hybrid
Director/Executive
$265K/yr - $315K/yrCareDx, Inc. is a leading precision medicine solutions company focused on transplant patients and caregivers. The Medical Director Oncologist will lead efforts in clinical development strategies for cell therapy and bone marrow transplant monitoring products, including designing clinical trials and engaging with key stakeholders to support product launches.
BiotechnologyHealth CareHealth DiagnosticsInformation Technology
Responsibilities
Design and execute sponsored clinical studies and support registries, investigator initiated trials, grants, research collaborations, etc
Act as a senior company medical representative interacting with external scientific leaders, patient advocacy groups, payors, pharmaceutical companies, regulatory authorities, and others
Develop and execute a comprehensive abstracts and publication plan. Responsible for final abstract submissions and publications with input from key internal and external stakeholders and review by the leadership team
Present at conferences and other scientific exchange meetings; when needed work with external clinicians to present on CareDx’s behalf
Function as the primary clinical resource for the commercial team to provide scientific and clinical leadership in the development of strategies for product/business development
Organize and execute scientific and clinical advisory boards
Work with clinical operations and medical affairs, be able to propose, implement, and monitor clinical studies
Support scientific and clinical initiatives at key clinical and scientific meetings
Coordinate with the CareDx organization to ensure the proper resources are in place to support new clinical opportunities
Work closely with VP of Cell Therapy and Transplant, R&D and business development to evaluate new opportunities
Qualification
Required
Oncologist Medical degree and experience beyond training required for the Medical Director role
Experience in leading clinical research and publications
Understanding of diagnostic and molecular monitoring tests for hematologic malignancies, particularly for patients undergoing cell therapy or bone marrow treatment
Results-orientation – track record for delivering results, taking ownership and accountability
Strong initiative, creativity, independence, sense of urgency, self-motivation, and time management skills
Comfortable presenting to and partnering with executives, key thought leaders in the field, and with cross-functional partners to solve complex business challenges
Desire to work in a high growth and results-oriented team environment
Unrelenting intellectual curiosity
Travel required, up to 40%
Preferred
Prior industry experience in cell therapy therapeutics or diagnostics
Benefits
Competitive base salary and incentive compensation
Health and welfare benefits, including a gym reimbursement program
401(k) savings plan match
Employee Stock Purchase Plan
Pre-tax commuter benefits
Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
Company
CareDx, Inc.
CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc.
Founded in 1998
501-1000 employees
H1B Sponsorship
CareDx, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (8)
2023 (4)
2022 (22)
2021 (21)
2020 (9)
Funding
Current Stage
Public CompanyTotal Funding
$574.89MKey Investors
Bristol-Myers SquibbSprout Group
2021-01-21Post Ipo Equity· $164M
2020-06-09Post Ipo Equity· $117.1M
2018-11-13Post Ipo Equity· $52.8M
Leadership Team
John Hanna
Chief Executive Officer
Nathan Smith
Chief Financial Officer
Recent News
2026-01-06
2025-12-20
Morningstar.com
2025-12-19
Company data provided by crunchbase